DARKPOOL0.1.0
AFT-MKT Sign in
CARL
Carlsmed, Inc.
NMS Equity
18.60
+3.89 (+26.44%)
52w low 8.50 17.23 high
100.0% of range

Financial Analysis

Annual
Ratio Dec 23Dec 24Dec 25 Trend
Profitability
Gross Margin 71.9%73.8%75.3%
Operating Margin -134.9%-88.8%-60.5%
EBITDA Margin -131.5%-83.9%-55.3%
Net Margin -137.2%-89.3%-58.7%
FCF Margin -127.8%-94.4%-60.1%
Returns
Return on Equity 41.0%34.3%-30.0%
Return on Assets -134.8%-46.8%-22.8%
Return on Inv Capital 39.2%32.8%-19.5%
Liquidity
Current Ratio 1.58x5.60x8.87x
Quick Ratio 1.50x5.48x8.74x
Cash Ratio 0.97x4.55x6.01x
Leverage
Debt / Equity -0.25x-0.24x0.18x
Net Debt / EBITDA -0.12x----
Interest Coverage -28.48x-17.36x-19.72x
Equity Multiplier -0.30x-0.73x1.32x
Efficiency
Asset Turnover 0.98x0.52x0.39x
Inventory Turnover 6.74x7.15x6.76x
Op CF / Net Income 0.92x1.05x0.98x
Investment
Capex / Revenue 1.0%0.7%2.7%
R&D / Revenue 53.7%52.7%33.7%
SG&A / Revenue 153.1%109.9%102.1%
Revenue CAGR
+91.5%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+85.9%